Skip to main content
GIPResearch.com · Patent and Technology Research

THE BRIGHAM AND WOMEN'S HOSPITAL, INC. GRANTED PATENT FOR OLIGOSACCHARIDE BEARING AN O-LINKED LINKER.

The Brigham and Women's Hospital, Inc. (BWH) is known for its services in healthcare. The Hospital provides patients with cancer therapy and treatment, cardiovascular, neurosciences, orthopedic, arthritis, women's fitness, nursing, nutrition, pharmacy, and primary healthcare assistance. BWH serves…

Save or follow this source
These actions open third-party AI services. Saving, citation, and future recall are not guaranteed.
Conceptual GIPResearch illustration for THE BRIGHAM AND WOMEN'S HOSPITAL, INC. GRANTED PATENT FOR OLIGOSACCHARIDE BEARING AN O-LINKED LINKER
Research and original publication material

THE BRIGHAM AND WOMEN'S HOSPITAL, INC. GRANTED PATENT FOR OLIGOSACCHARIDE BEARING AN O-LINKED LINKER. — research background

Research context: This article preserves existing publication material for continuity. Technical, commercial and legal references should be checked against current primary sources before making decisions.

The Brigham and Women's Hospital, Inc. (BWH) is known for its services in healthcare. The Hospital provides patients with cancer therapy and treatment, cardiovascular, neurosciences, orthopedic, arthritis, women's fitness, nursing, nutrition, pharmacy, and primary healthcare assistance. BWH serves patients in the State of Massachusetts. In India the business of the Brigham and Women's Hospital, Inc. focuses on compositions and related methods for targeted drug delivery, MSC-expressed immunomodulators in combination with car-t for cancer therapy, elastic biopolymer and use as a tissue adhesive, methods, and compositions relating to the treatment of cancer and parp9 and parp14 as key regulators of macrophage activation. The Brigham and Women's Hospital, Inc. (BWH) filed a patent application numbered 201818000672 that is titled OLIGOSACCHARIDE BEARING AN O-LINKED LINKER. The patent has been filed in the field of Pharmaceuticals. This Patent Application has been granted as Patent Number 352886. This invention relates to an oligosaccharide bearing an O-linked linker, wherein the linker comprises and wherein the oligosaccharide is β-1-6 linked glucosamine. During the patent examination, the Patent Examiner raised objections under Section 3(d) of the Patents Act, 1970 stating that with respect to the cited documents, the same or similar compounds are already known in the art. As a response, the Applicant submitted that neither D1 nor D2 discloses the linker of the claims. Since the claimed linker is novel and does not constitute a new form of any linkers known from D1 or D2, the prescription under Section 3 (d) does not apply to the claims. Advocate Rahul Dev is a Patent Attorney & International Business Lawyer practicing Technology, Intellectual Property & Corporate Laws. He is reachable at rd (at) patentbusinesslawyer (dot) com & @rdpatentlawyer on Twitter. Quoted in and contributed to 50+ national & international publications (Bloomberg, FirstPost, SwissInfo, Outlook Money, Yahoo News, Times of India, Economic Times, Business Standard, Quartz, Global Legal Post, International Bar Association, LawAsia, BioSpectrum Asia, Digital News Asia, e27, Leaders Speak, Entrepreneur India, VCCircle, AutoTech). Regularly invited to speak at international & national platforms (conferences, TV channels, seminars, corporate trainings, government workshops) on technology, patents, business strategy, legal developments, leadership & management.

Discuss a research question related to THE BRIGHAM AND WOMEN'S HOSPITAL, INC. GRANTED

Describe your objective and the evidence you need. The suitability and scope of any research engagement will be confirmed individually.

Discuss a research question

Source and context: Original GIPResearch.com publication dated 2020-12-10. Existing text is retained for historical continuity. Verify time-sensitive matters using official records.

None

Featured Work & Insights